Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects

被引：0
|
作者：
Chanan Shaul
Simcha Blotnick
Mordechai Muszkat
Meir Bialer
Yoseph Caraco
机构：
[1] Hadassah-Hebrew University Medical Center,Clinical Pharmacology Unit, Division of Medicine
[2] Hebrew University,Institute of Drug Research, School of Pharmacy, Faculty of Medicine
来源：
Molecular Diagnosis & Therapy | 2017年 / 21卷
关键词：
Warfarin; Variant Allele; Warfarin Dose; Oral Clearance; CYP2C9 Genotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 83
页数：8
相关论文
共 50 条
  • [41] Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects
    Sabia, H
    Sunkara, G
    Ligueros-Saylan, M
    Wang, YB
    Smith, H
    McLeod, J
    Prasad, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (06) : 407 - 412
  • [42] Analysis of CYP2C9 polymorphisms (*2 and*3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR
    Yasmeen, Faiza
    Ghafoor, Muhammad Bilal
    Khalid, Abdul Wadood
    Latif, Waqas
    Mohsin, Shahida
    Khaliq, Shagufta
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (02) : 218 - 224
  • [43] Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR
    Faiza Yasmeen
    Muhammad Bilal Ghafoor
    Abdul Wadood Khalid
    Waqas Latif
    Shahida Mohsin
    Shagufta Khaliq
    Journal of Thrombosis and Thrombolysis, 2015, 40 : 218 - 224
  • [44] The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation
    Gill, HJ
    Tjia, JF
    Kitteringham, NR
    Pirmohamed, M
    Back, DJ
    Park, BK
    PHARMACOGENETICS, 1999, 9 (01): : 43 - 53
  • [45] Determination of CYP2C9 and CYP2C19 genetic polymorphisms in Behcet's disease
    Tamer, L
    Yildirim, H
    Api, H
    Karakas, S
    Degirmenci, U
    Ayaz, L
    Ercan, B
    Baz, K
    Tursen, U
    Atik, U
    FEBS JOURNAL, 2005, 272 : 137 - 137
  • [46] Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
    Zhang, Yifan
    Si, Dayong
    Chen, Xiaoyan
    Lin, Nan
    Guo, Yingjie
    Zhou, Hui
    Zhong, Dafang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (01) : 67 - 74
  • [47] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Tan, Bo
    Zhang, Yi-Fan
    Chen, Xiao-Yan
    Zhao, Xiao-Hua
    Li, Guo-Xin
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 145 - 151
  • [48] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Bo Tan
    Yi-Fan Zhang
    Xiao-Yan Chen
    Xiao-Hua Zhao
    Guo-Xin Li
    Da-Fang Zhong
    European Journal of Clinical Pharmacology, 2010, 66 : 145 - 151
  • [49] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Hyun-Jee Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Ae-Yun Yang
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Chang-Ik Choi
    Archives of Pharmacal Research, 2016, 39 : 1013 - 1019
  • [50] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Lee, Hyun-Jee
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Yang, Ae-Yun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (07) : 1013 - 1019
12345